COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,008 Articles (21,508 medRxiv, 7,500 bioRxiv)

Most recent first Previous |  Page 1500: Articles 14991-15000  | Next

Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents
Haile, S., Nikiforuk, A. M., Pandoh, P. K., Twa, D. D. W., Smailus, D. E., Nguyen, J., Pleasance, S., Wong, A., Zhao, Y., Eisler, D., Moksa, M., Cao, Q., Wong, M., Su, E., Krzywinski, M., Nelson, J. M. T., Mungall, A. J., Tsang, F., Prentice, L. M., Jassem, A., Manges, A. R., Jones, S. J. M., Coope, R. J., Prystajecky, N., Marra, M. A., Krajden, M., Hirst, M.
10.1101/2021.03.09.21251364 — Posted: 2021-03-12
Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice
Silvas, J., Morales Vasquez, D., Park, J.-G., Chiem, K., Torrelles, J., Platt, R. N., Anderson, T., Ye, C., Martinez-Sobrido, L.
10.1101/2021.03.09.434696 — Posted: 2021-03-12
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
Benotmane, I., Gautier-Vargas, G., Cognard, N., Olagne, J., Heibel, F., Braun Parvez, L., Martzloff, J., Perrin, P., Moulin, B., Fafi-Kremer, S., Caillard, S.
10.1101/2021.03.08.21252741 — Posted: 2021-03-12
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
Wiens, K. E., Nyimol Mawien, P., Rumunu, J., Slater, D., Jones, F. K., Moheed, S., Caflish, A., Bior, B. K., Amanaya Iboyi, J., Lino Loro Lako, R., Guracha Guyo, A., Oluseun Olu, O., Maleghemi, S., Baguma, A., John Hassen, J., Baya, S. K., Deng, L., Lessler, J., Demby, M. N., Sanchez, V., Mills, R., Fraser, C., Charles, R. C., Harris, J. B., Azman, A. S., Wamala, J. F.
10.1101/2021.03.08.21253009 — Posted: 2021-03-12
Changes in eating habits and lifestyles in Peruvian population during social isolation by the COVID-19 pandemic
Huancahuire-Vega, S., Newball-Noriega, E. E., Rojas-Humpire, R., Saintila, J., Rodriguez Vasquez, M., Ruiz-Mamani, P., Morales-Garcia, W., White, M.
10.1101/2021.03.08.21252979 — Posted: 2021-03-12
Evaluating the impacts of tiered restrictions introduced in England, during October and December 2020 on COVID-19 cases: A synthetic control study.
Zhang, X., Owen, G., Green, M., Buchan, I., Barr, B.
10.1101/2021.03.09.21253165 — Posted: 2021-03-12
Process evaluation of the development and remote recruitment for Essential Coaching for Every Mother during COVID-19
Dol, J., Tomblin Murphy, G., McMillan, D., Aston, M., Campbell-Yeo, M.
10.1101/2021.03.09.21253071 — Posted: 2021-03-12
May we overcome the current serious limitations for distributing reconstituted mRNA vaccines?
Grau, S., Ferrandez, O., Martin-Garcia, E., Maldonado, R.
10.1101/2021.03.09.21253129 — Posted: 2021-03-12
Universal Rule for Covid 19 and Herd Immunity in the US
Kuriyan, J.
10.1101/2021.03.05.21251577 — Posted: 2021-03-12
SARS-CoV-2 antibody prevalence and determinants of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020
Coyer, L., Boyd, A., Schinkel, J., Agyemang, C., Galenkamp, H., Koopman, A. D. M., Leenstra, T., Moll van Charante, E. P., van den Born, B.-J. H., Lok, A., Verhoeff, A., Zwinderman, A. H., Jurriaans, S., van Vught, L. A., Stronks, K., Prins, M.
10.1101/2021.03.08.21252788 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).